Holland Capital Announces Successful Exit of Defibrion to IK Partners
Amsterdam/Groningen, 23 July 2024 – Holland Capital is proud to announce that IK Partners (IK) has signed an agreement to acquire our portfolio company, Defibrion. Since 2019, Defibrion’s management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company’s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.
Defibrion: A Leading Provider in AED Distribution and Safety Products
Founded in 2008 by the current CEO Joshua Valkenier and based in Groningen, Defibrion is a market leader in the distribution of automated external defibrillators (AEDs) and related safety products. The company offers a wide range of products and services aimed at enhancing workplace safety. With over 6,400 customers worldwide, Defibrion serves as a one-stop-shop for emergency response needs. Its customer base, which includes more than 900 resellers in Europe and North America, comprises various end users such as offices, sports clubs, and government institutions.
Strategic Growth and Expansion
Since 2019, Holland Capital has been involved with Defibrion as a shareholder. They actively supported the management in professionalizing the organization and the strategic development of the company. Through a successful buy-and-build strategy and a focus on geographical expansion in Western Europe, Defibrion has been able to grow successfully.
Defibrion is now on the brink of a new phase in its development, which will be supported by IK. In this new phase, Defibrion will further scale up its existing operations, broaden its offerings, and expand into new markets. The strategic plan also includes exploring further buy-and-build opportunities to promote consolidation in the fragmented market of AEDs and related safety products.
Joshua Valkenier, founder and CEO of Defibrion, said: “When Holland Capital joined Defibrion as a shareholder in 2019, we had the ambition to internationalize, professionalize, and further expand our organization. I am pleased that we have achieved this and am grateful to Holland Capital for the pleasant and successful collaboration.”
Ewout Prins, managing partner of Holland Capital, commented: “The collaboration with Joshua Valkenier and the Defibrion team was both successful and enjoyable. When we joined, we were convinced that the AED market offered interesting growth opportunities, and Defibrion has demonstrated this. Their dedication and vision have played a crucial role in achieving this growth. We are proud to have contributed to the successful growth of Defibrion and its life-saving products. We wish the team much success in this next phase of growth.”
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
cards PLM Solutions takes the first step in the buy-and-build strategy with the acquisition of Settels Savenije PLM Services
cards PLM Solutions takes the first step in the buy-and-build strategy with the acquisition of Settels Savenije PLM ServicesAmsterdam / Best, September 29, 2021 – cards PLM Solutions, Product Lifecycle Management (PLM) solutions provider, takes the next step in its...
Valori takes first step in buy-and-build strategy with acquisition of Omnext
Valori takes first step in buy-and-build strategy with acquisition of OmnextUtrecht/Amsterdam, July 8th 2021 – Valori takes a majority stake in Omnext, a leading international player in software code analysis. The joining of forces, made possible by Holland Capital,...
Xilloc raises growth financing from Holland Capital
Xilloc raises growth financing from Holland Capital Geleen/Amsterdam, July 2nd 2021 - Xilloc, a leading innovator and producer of medical implants and devices, has raised growth finance for its international expansion and product development from Holland Capital....
Yes We Can Healthcare Group joins forces with Holland Capital
Yes We Can Healthcare Group joins forces with Holland Capital Hilvarenbeek / Amsterdam, 1st of July 2021 – Holland Capital joins forces with Yes We Can Healthcare Group (YWCHG), a mental healthcare clinic for young people between 13 and 23 with addictions and...
Sirius Medical Establishes Highly Experienced Supervisory Board and Announces CEO Transition
Sirius Medical establishes highly experienced Supervisory Board and announces CEO transition Eindhoven, May 11th 2021 - Sirius Medical, a medical device start-up developing the next generation of tumor localization technology, today announced that medical device...
Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion
Digital R&D simulation software platform RheoCube attracts funding of 2 million USD for international expansion Amsterdam, 17 February 2021 – Digital R&D simulation software platform RheoCube has attracted an investment of over 2 million USD. This funding...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl